| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-pim-1 | 5 | 2015 | 87 | 1.800 |
Why?
|
| Colorectal Neoplasms | 4 | 2022 | 561 | 1.250 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2017 | 331 | 0.950 |
Why?
|
| MicroRNAs | 4 | 2021 | 447 | 0.810 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2021 | 14 | 0.780 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 30 | 0.770 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 231 | 0.740 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 332 | 0.720 |
Why?
|
| Dinoprostone | 2 | 2022 | 110 | 0.700 |
Why?
|
| S-Phase Kinase-Associated Proteins | 2 | 2010 | 9 | 0.700 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 306 | 0.670 |
Why?
|
| RNA, Small Interfering | 5 | 2021 | 434 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2022 | 331 | 0.650 |
Why?
|
| bcl-X Protein | 1 | 2017 | 36 | 0.600 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 64 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 174 | 0.570 |
Why?
|
| Up-Regulation | 3 | 2019 | 682 | 0.540 |
Why?
|
| Cell Line, Tumor | 10 | 2021 | 1851 | 0.530 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 468 | 0.510 |
Why?
|
| Mice | 15 | 2022 | 8474 | 0.490 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 135 | 0.480 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2014 | 11 | 0.480 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2014 | 33 | 0.470 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 63 | 0.460 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 223 | 0.450 |
Why?
|
| RNA, Long Noncoding | 3 | 2019 | 54 | 0.450 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1173 | 0.430 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 100 | 0.420 |
Why?
|
| Mice, Nude | 4 | 2017 | 294 | 0.410 |
Why?
|
| Arrestins | 3 | 2001 | 92 | 0.400 |
Why?
|
| Peptides, Cyclic | 3 | 2021 | 35 | 0.390 |
Why?
|
| Animals | 18 | 2022 | 20881 | 0.370 |
Why?
|
| Melatonin | 2 | 2021 | 39 | 0.370 |
Why?
|
| Receptors, Opioid, delta | 2 | 2001 | 37 | 0.370 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 304 | 0.340 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2008 | 8 | 0.330 |
Why?
|
| Neoplasms | 2 | 2021 | 1667 | 0.330 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2008 | 26 | 0.330 |
Why?
|
| HeLa Cells | 3 | 2014 | 237 | 0.310 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 778 | 0.300 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 216 | 0.300 |
Why?
|
| Phosphorylation | 5 | 2016 | 1200 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 290 | 0.280 |
Why?
|
| Random Allocation | 3 | 2021 | 442 | 0.280 |
Why?
|
| Endometrium | 2 | 2016 | 31 | 0.270 |
Why?
|
| Humans | 24 | 2022 | 68618 | 0.250 |
Why?
|
| Signal Transduction | 6 | 2020 | 2689 | 0.250 |
Why?
|
| Transfection | 3 | 2015 | 782 | 0.250 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2016 | 126 | 0.250 |
Why?
|
| RNA Interference | 2 | 2017 | 266 | 0.250 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 334 | 0.250 |
Why?
|
| Cell Line | 6 | 2010 | 1752 | 0.240 |
Why?
|
| Immunoblotting | 2 | 2015 | 254 | 0.210 |
Why?
|
| Cyclooxygenase 2 | 2 | 2022 | 160 | 0.210 |
Why?
|
| Sp1 Transcription Factor | 2 | 2015 | 21 | 0.210 |
Why?
|
| Protein Binding | 3 | 2014 | 1027 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 32 | 0.200 |
Why?
|
| HT29 Cells | 1 | 2021 | 42 | 0.200 |
Why?
|
| Tumor Escape | 1 | 2021 | 37 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 498 | 0.190 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2001 | 37 | 0.190 |
Why?
|
| Adenoma | 1 | 2022 | 132 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 196 | 0.180 |
Why?
|
| Receptors, Opioid, mu | 1 | 2001 | 70 | 0.180 |
Why?
|
| HEK293 Cells | 1 | 2021 | 326 | 0.180 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 10 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 2791 | 0.180 |
Why?
|
| Cyclooxygenase 1 | 1 | 2019 | 29 | 0.170 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 57 | 0.170 |
Why?
|
| Ubiquitination | 2 | 2010 | 85 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 266 | 0.170 |
Why?
|
| Cisplatin | 1 | 2020 | 192 | 0.170 |
Why?
|
| Transcriptome | 1 | 2020 | 164 | 0.160 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2018 | 3 | 0.160 |
Why?
|
| STAT Transcription Factors | 1 | 2018 | 13 | 0.160 |
Why?
|
| Polygeline | 1 | 2018 | 1 | 0.160 |
Why?
|
| Renal Elimination | 1 | 2018 | 2 | 0.160 |
Why?
|
| Janus Kinases | 1 | 2018 | 11 | 0.160 |
Why?
|
| Chemokine CXCL10 | 1 | 2018 | 21 | 0.160 |
Why?
|
| Cell Cycle | 2 | 2018 | 312 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 300 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 163 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 852 | 0.150 |
Why?
|
| Mice, Knockout | 2 | 2014 | 1692 | 0.150 |
Why?
|
| RNAi Therapeutics | 1 | 2017 | 3 | 0.150 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 226 | 0.150 |
Why?
|
| Aniline Compounds | 1 | 2017 | 52 | 0.150 |
Why?
|
| Kidney | 2 | 2018 | 945 | 0.150 |
Why?
|
| Chemokine CXCL1 | 1 | 2017 | 21 | 0.150 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 371 | 0.140 |
Why?
|
| Drug Synergism | 1 | 2017 | 260 | 0.140 |
Why?
|
| Heterografts | 2 | 2017 | 70 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 508 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 173 | 0.140 |
Why?
|
| Sulfonamides | 1 | 2017 | 141 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 170 | 0.140 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 45 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 247 | 0.140 |
Why?
|
| Culture Media | 1 | 2016 | 155 | 0.140 |
Why?
|
| Smad3 Protein | 1 | 2016 | 33 | 0.130 |
Why?
|
| Smad2 Protein | 1 | 2016 | 42 | 0.130 |
Why?
|
| ErbB Receptors | 1 | 2017 | 239 | 0.130 |
Why?
|
| Smad Proteins | 1 | 2015 | 25 | 0.130 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 232 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 189 | 0.130 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2015 | 76 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 209 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2017 | 219 | 0.120 |
Why?
|
| Algorithms | 1 | 2020 | 1196 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1997 | 626 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2014 | 5 | 0.120 |
Why?
|
| Thiazolidines | 1 | 2014 | 23 | 0.120 |
Why?
|
| Male | 8 | 2018 | 37321 | 0.120 |
Why?
|
| Rats | 4 | 2016 | 5300 | 0.120 |
Why?
|
| Flow Cytometry | 2 | 2016 | 489 | 0.120 |
Why?
|
| Prostate | 1 | 2014 | 116 | 0.110 |
Why?
|
| Amino Acid Sequence | 3 | 2001 | 1083 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 181 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2020 | 1174 | 0.110 |
Why?
|
| Biphenyl Compounds | 1 | 2014 | 184 | 0.110 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 40 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2016 | 2673 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 369 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1070 | 0.110 |
Why?
|
| Stromal Cells | 3 | 2020 | 113 | 0.110 |
Why?
|
| beta-Arrestins | 3 | 2001 | 80 | 0.110 |
Why?
|
| Escherichia coli | 3 | 2001 | 368 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2014 | 562 | 0.100 |
Why?
|
| Cell Movement | 1 | 2014 | 630 | 0.100 |
Why?
|
| Binding Sites | 3 | 2001 | 631 | 0.090 |
Why?
|
| Brain Ischemia | 1 | 2016 | 665 | 0.090 |
Why?
|
| Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2010 | 5 | 0.090 |
Why?
|
| S Phase | 1 | 2010 | 38 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 272 | 0.090 |
Why?
|
| Cadherins | 1 | 2010 | 93 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2014 | 902 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2010 | 230 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 756 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 38 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2001 | 742 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 69 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 1447 | 0.080 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2018 | 15 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 230 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2001 | 362 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2018 | 282 | 0.080 |
Why?
|
| Apoptosis | 3 | 2020 | 1641 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 213 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 532 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 615 | 0.070 |
Why?
|
| Collagen Type I | 2 | 2016 | 175 | 0.060 |
Why?
|
| Fibrosis | 2 | 2016 | 371 | 0.060 |
Why?
|
| Stroke | 1 | 2016 | 2163 | 0.060 |
Why?
|
| Female | 4 | 2021 | 38074 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1664 | 0.050 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2022 | 12 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 87 | 0.050 |
Why?
|
| beta-Arrestin 1 | 1 | 2001 | 22 | 0.050 |
Why?
|
| Threonine | 1 | 2001 | 47 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 2083 | 0.050 |
Why?
|
| Serine | 1 | 2001 | 99 | 0.050 |
Why?
|
| Cytosol | 1 | 2001 | 123 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 204 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2020 | 52 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 30 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2021 | 183 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 357 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 218 | 0.050 |
Why?
|
| Genomics | 1 | 2021 | 168 | 0.050 |
Why?
|
| Data Mining | 1 | 2020 | 45 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 322 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 94 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 420 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2001 | 166 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 240 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 349 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2000 | 48 | 0.040 |
Why?
|
| beta Catenin | 1 | 2020 | 73 | 0.040 |
Why?
|
| Pyridines | 1 | 2021 | 261 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 2550 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 376 | 0.040 |
Why?
|
| Endocytosis | 1 | 2000 | 113 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2001 | 483 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2018 | 137 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1745 | 0.040 |
Why?
|
| Glioma | 1 | 2018 | 140 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2017 | 7 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1997 | 26 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2017 | 132 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1997 | 89 | 0.040 |
Why?
|
| Protein Folding | 1 | 1997 | 82 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 1997 | 136 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 446 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2017 | 63 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 138 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1465 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 236 | 0.030 |
Why?
|
| Serum | 1 | 2016 | 24 | 0.030 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2016 | 22 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 238 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 317 | 0.030 |
Why?
|
| Neuroprotection | 1 | 2016 | 28 | 0.030 |
Why?
|
| Cell Death | 1 | 1997 | 329 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 84 | 0.030 |
Why?
|
| Base Sequence | 1 | 2016 | 1015 | 0.030 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2014 | 10 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 23 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 147 | 0.030 |
Why?
|
| Computer Simulation | 1 | 1997 | 706 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 244 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2014 | 431 | 0.030 |
Why?
|
| Models, Biological | 1 | 2014 | 981 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1293 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 4655 | 0.020 |
Why?
|
| beta-Arrestin 2 | 1 | 2000 | 29 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 60 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 21403 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1997 | 181 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 258 | 0.010 |
Why?
|
| Macrophages | 1 | 1997 | 647 | 0.010 |
Why?
|